[Correction of bronchial hyperreactivity with Corinfar in patients with chronic renal insufficiency].
As shown in the provocative tests in eighteen 24-42 year old chronics with renal insufficiency, corinfar pretreatment (20 mg sublingually) can protect against acetylcholine-induced bronchial hyperreactivity. This ability of the drug can be useful to reduce hyperreactivity of the bronchi of patients with chronic renal insufficiency.